中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Detection of nanocarrier potentiation on drug induced phospholipidosis in cultured cells and primary hepatocyte spheroids by high content imaging and analysis

文献类型:期刊论文

作者Zhang, Xihui4; Yang, Liecheng4; Liu, Yongming4; Song, Zhentao3; Zhao, Jian3; Chen, Dandan; Yu, Huan; Li, Ruibin; Wang, Yangyun; Yang, Kai
刊名TOXICOLOGY AND APPLIED PHARMACOLOGY
出版日期2018
卷号348页码:54
关键词Phospholipidosis Nanocarrier Primary hepatocyte Spheroid High content screening
ISSN号0041-008X
DOI10.1016/j.taap.2018.04.016
英文摘要Considerable effort has been made to develop nanocarriers for controlled drug delivery over the last decade, while it remains unclear how the strength of adverse drug effect will be altered when a drug is loaded on the nanocarrier. Drug-induced phospholipidosis (DIP) is characterized with excessive accumulation of phospholipids in cells and is common for cationic amphiphilic drugs (CAD). Previously, we have reported that PEGylated graphene oxide (PEG-GO) loaded with several CAD can potentiate DIP. In current study, we extended our study on newly identified phospholipidosis (PLD) inducers that had been identified from the Library of Pharmacologically Active Compounds (LOPAC), to investigate if PEO-GO loaded with these CAD can alter DIP. Twenty-two CAD were respectively loaded on PEG-GO and incubated with RAW264.7, a macrophage cell line. The results showed that when a CAD was loaded on PEG-GO, its strength of PLD induction can be enhanced, unchanged or attenuated. PEG-GO loaded with Ifenprodil exhibited the highest PEG-GO potentiation effect compared to Ifenprodil treatment alone in RAW264.7 cells, and this effect was confirmed in human hepatocellular carcinoma HepG2, another cell line model for PLD induction. Primary hepatocyte culture and spheroids mimicking in vivo conditions were used to further validate nanocarrier potentiation on DIP by Ifenprodil. Stronger phospholipid accumulation was found in PEG-GO/Ifenprodil treated hepatocytes or spheroids than Ifenprodil treatment alone. Therefore, evidences were provided by us that nanocarriers may increase the adverse drug effects and guidance by regulatory agencies need to be drafted for the safe use of nanotechnology in drug delivery.
学科主题Pharmacology & Pharmacy ; Toxicology
WOS记录号WOS:000432634300006
出版者ACADEMIC PRESS INC ELSEVIER SCIENCE
资助机构The authors would like to thank the National Natural Science Foundation of China (#81401511, #31771104, #31400861, #11304212), Key Project of Natural Science Foundation of the Higher Education Institutions of Jiangsu Province (17KJA310003), Natural Science Foundation of Jiangsu Province (BK20130279), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection for financial support. ; The authors would like to thank the National Natural Science Foundation of China (#81401511, #31771104, #31400861, #11304212), Key Project of Natural Science Foundation of the Higher Education Institutions of Jiangsu Province (17KJA310003), Natural Science Foundation of Jiangsu Province (BK20130279), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection for financial support.
源URL[http://ir.sic.ac.cn/handle/331005/24893]  
专题中国科学院上海硅酸盐研究所
作者单位1.[Zhang, Xihui; Yang, Liecheng; Liu, Yongming; Chen, Dandan; Yu, Huan; Li, Ruibin; Wang, Yangyun; Yang, Kai; Zhang, Leshuai W.] Soochow Univ, Collaborat Innovat Ctr Radiat Med Jiangsu Higher, Sch Radiol & Interdisciplinary Sci RAD X, State Key Lab Radiat Med & Protect,Sch Radiat Med, Suzhou 215123, Peoples R China
2.NIH, Natl Ctr Advancing Translat Sci, Bldg 10, Bethesda, MD 20892 USA
3.Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China
4.East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China
5.Soochow Univ, Sch Biol & Basic Med Sci, Suzhou 215123, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Xihui,Yang, Liecheng,Liu, Yongming,et al. Detection of nanocarrier potentiation on drug induced phospholipidosis in cultured cells and primary hepatocyte spheroids by high content imaging and analysis[J]. TOXICOLOGY AND APPLIED PHARMACOLOGY,2018,348:54, 66.
APA Zhang, Xihui.,Yang, Liecheng.,Liu, Yongming.,Song, Zhentao.,Zhao, Jian.,...&Zhang, Leshuai W..(2018).Detection of nanocarrier potentiation on drug induced phospholipidosis in cultured cells and primary hepatocyte spheroids by high content imaging and analysis.TOXICOLOGY AND APPLIED PHARMACOLOGY,348,54.
MLA Zhang, Xihui,et al."Detection of nanocarrier potentiation on drug induced phospholipidosis in cultured cells and primary hepatocyte spheroids by high content imaging and analysis".TOXICOLOGY AND APPLIED PHARMACOLOGY 348(2018):54.

入库方式: OAI收割

来源:上海硅酸盐研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。